BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

TaiGen Biotechnology 



Nei-Hu  Taipei    Taiwan
Phone: N/A Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Start Up





 Company News
ScinoPharm To Provide Active Pharmaceutical Ingredient To TaiGen Biotechnology For Novel Stem Cell Drug 6/9/2014 10:17:55 AM
TaiGen Biotechnology Granted Taiwanese Approval For Novel Antibiotic 3/13/2014 11:05:33 AM
TaiGen Biotechnology Raises $36 Million In Taiwan IPO 1/20/2014 1:44:50 PM
TaiGen Biotechnology Signed Exclusive License Agreement With R-Pharm For Nemonoxacin (Taigexyn®) 1/15/2014 8:00:55 AM
TaiGen Biotechnology Expects China Launch Of Novel Antibiotic In 2014 1/6/2014 11:23:29 AM
TaiGen Biotechnology Receives Qualified Infectious Disease Product And Fast Track Designations From The FDA For Nemonoxacin (Taigexyn®) 12/23/2013 9:04:17 AM
TaiGen Biotechnology Reports Phase IIa Data for TG-0054 at the 2013 American Society of Hematology Annual Meeting 10/30/2013 6:55:02 AM
TaiGen Biotechnology Announces Submission of New Drug Application for Nemonoxacin in Taiwan and Mainland China 5/16/2013 10:06:47 AM
ZMC Nabs Chinese Rights to TaiGen Biotechnology's Phase III-Stage Antibiotic for $8 Million 6/25/2012 7:49:33 AM
TaiGen Biotechnology Obtains the Worldwide Rights for Nemonoxacin 12/9/2011 6:58:03 AM
123